---
title: GBM129 GBM Model - TD2 Precision Oncology
description: Bridging the gap between lab and clinic with GBM129 PDX in Brain Cancer research.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/gbm129.png
---
×
[](https://td2inc.com/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
# GBM129 GBM Model
GBM129-derived PDX is a pivotal link between laboratory research and clinical success in Brain Cancer treatment. Its ability to closely mirror patient responses empowers researchers to investigate the effectiveness of therapies with unparalleled precision. GBM129 PDX is instrumental in the development of novel treatment strategies for Brain Cancer, guiding researchers towards safer, more effective, and tailored therapies for patients. It plays a central role in advancing preclinical drug discovery in Brain Cancer.
## Model Details
**Cancer Location:** Intracranial
**Cancer Type:** Brain Cancer
**Model Name:** GBM129
**Mouse Strain:** Nu/Nu
**Treatment Data Available:** Chemotherapy (Temozolomide)
**WES:** Yes
**RNAseq:** Yes
**Methylation:** Yes
**PDX Treatment:** Yes
**Patient Treatment History:** Yes
## GBM129 Survival
Survival of orthotopic intracranial implanted GBM129 in Nu/Nu mice (n=5)
### Request Additional GBM Model Data
## CONTACT US
## Get Started.
Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.
[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
Office
13208 E. Shea Blvd,
Suite 100
Scottsdale, AZ 85259
Phone
(602) 358-8300
Connect with us
-
-
© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)